Author:
Qin Xiuguang,Yao Wenjian,Li Weiwei,Feng Xianjun,Huo Xiaoqing,Yang Shujuan,Zhao Hui,Gu Xiaomeng
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. International Agency for Research on Cancer. Globocan 2008: Lung cancer incidence, mortality and prevalence worldwide in 2008. Summary. http://globocan.iarc.fr/factsheet.asp .
2. Bartolucci R, Wei J, Sanchez JJ, Perez-Roca L, Chaib I, Puma F, et al. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. Clin Lung Cancer. 2009;10(1):47–52.
3. Pesta M, Kulda V, Fiala O, Safranek J, Topolcan O, Krakorova G, et al. Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer. Anticancer Res. 2012;32(11):5003–10.
4. Su C, Zhou S, Zhang L, Ren S, Xu J, Zhang J, et al. ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer. Med Oncol. 2011;28(4):1411–7.
5. Bidoli P, Zilembo N, Cortinovis D, Mariani L, Isa L, Aitini E, et al. Randomized phase II three-arm trial with three platinum-based doublets in metastatic nonsmall-cell lung cancer. An Italian Trials in Medical Oncology Study. Ann Oncol. 2007;18:461–7.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献